100 related articles for article (PubMed ID: 9756886)
1. Purification, characterization, and kinetic mechanism of cyclin D1. CDK4, a major target for cell cycle regulation.
Konstantinidis AK; Radhakrishnan R; Gu F; Rao RN; Yeh WK
J Biol Chem; 1998 Oct; 273(41):26506-15. PubMed ID: 9756886
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
Kim DM; Yang K; Yang BS
Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
[TBL] [Abstract][Full Text] [Related]
3. Characterization of novel inhibitors of cyclin-dependent kinases.
Kent LL; Hull-Campbell NE; Lau T; Wu JC; Thompson SA; Nori M
Biochem Biophys Res Commun; 1999 Jul; 260(3):768-74. PubMed ID: 10403840
[TBL] [Abstract][Full Text] [Related]
4. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
6. Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex.
Pan W; Sun T; Hoess R; Grafstrom R
Carcinogenesis; 1998 May; 19(5):765-9. PubMed ID: 9635861
[TBL] [Abstract][Full Text] [Related]
7. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
Pan W; Cox S; Hoess RH; Grafström RH
Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
[TBL] [Abstract][Full Text] [Related]
8. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
[TBL] [Abstract][Full Text] [Related]
9. Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.
Wallace M; Ball KL
Mol Cell Biol; 2004 Jun; 24(12):5606-19. PubMed ID: 15169919
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
11. In vitro antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00.
Joshi KS; Rathos MJ; Joshi RD; Sivakumar M; Mascarenhas M; Kamble S; Lal B; Sharma S
Mol Cancer Ther; 2007 Mar; 6(3):918-25. PubMed ID: 17363486
[TBL] [Abstract][Full Text] [Related]
12. Defining the substrate specificity of cdk4 kinase-cyclin D1 complex.
Grafstrom RH; Pan W; Hoess RH
Carcinogenesis; 1999 Feb; 20(2):193-8. PubMed ID: 10069453
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription.
Adnane J; Shao Z; Robbins PD
Oncogene; 1999 Jan; 18(1):239-47. PubMed ID: 9926939
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
Diehl JA; Zindy F; Sherr CJ
Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
[TBL] [Abstract][Full Text] [Related]
15. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
16. The cyclin D1-dependent kinase associates with the pre-replication complex and modulates RB.MCM7 binding.
Gladden AB; Diehl JA
J Biol Chem; 2003 Mar; 278(11):9754-60. PubMed ID: 12519773
[TBL] [Abstract][Full Text] [Related]
17. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
Kato J; Matsushime H; Hiebert SW; Ewen ME; Sherr CJ
Genes Dev; 1993 Mar; 7(3):331-42. PubMed ID: 8449399
[TBL] [Abstract][Full Text] [Related]
18. Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis.
Semczuk A; Jakowicki JA
Cancer Lett; 2004 Jan; 203(1):1-12. PubMed ID: 14670612
[TBL] [Abstract][Full Text] [Related]
19. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation.
Tamamori-Adachi M; Ito H; Sumrejkanchanakij P; Adachi S; Hiroe M; Shimizu M; Kawauchi J; Sunamori M; Marumo F; Kitajima S; Ikeda MA
Circ Res; 2003 Jan; 92(1):e12-9. PubMed ID: 12522130
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Shan L; Yu M; Snyderwine EG
Cancer Res; 2003 Sep; 63(18):5674-8. PubMed ID: 14522882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]